Goldman Sachs’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-197,900
Closed -$2.46M – 6049
2022
Q3
$2.46M Buy
+197,900
New +$3.46M ﹤0.01% 3806
2019
Q4
– Sell
-97,900
Closed -$2.6M – 5258
2019
Q3
$2.6M Buy
+97,900
New +$2.94M ﹤0.01% 3358

Other funds holding ELAN

Goldman Sachs's ELAN Position: Q2 2026 in Review

Goldman Sachs reduced its Elanco Animal Health (ELAN) stake by 1.5% in Q2 2026, selling an estimated $507K and leaving 1,412,190 shares worth $34.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

Goldman Sachs first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $345M in Q2 2021. 524 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Goldman Sachs held 1,412,190 shares of Elanco Animal Health worth $34.8M as of Q2 2026.
  • Goldman Sachs sold 21,945 Elanco Animal Health shares in Q2 2026, an estimated $507K.
  • Elanco Animal Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2126 holding.
  • Goldman Sachs first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
  • Goldman Sachs's Elanco Animal Health position peaked at $345M in Q2 2021.
  • 524 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.